Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MeiraGTx
Biotech
MeiraGTx Parkinson's gene therapy boosts motor function in ph. 2
A one-time infusion into the brain's subthalamic nucleus improved motor ability and quality of life in a phase 2 trial with 14 patients.
Darren Incorvaia
Oct 15, 2024 7:00am
MeiraGTx gifts last of gene therapy rights to J&J for $415M
Dec 21, 2023 10:14am
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 1:06pm
MeiraGTx gene therapy for ALS rescues deficits in rodents
Oct 29, 2023 3:50pm
J&J links gene therapy to improved vision in early-phase trial
Oct 3, 2022 8:00am
